| Literature DB >> 33887865 |
Shiori Saeki1, Johji Imura2, Tadashi Bando3, Kazuto Shibuya4, Isaku Yoshioka5, Tsutomu Fujii6.
Abstract
INTRODUCTION AND IMPORTANCE: An intramural cyst is a rare lesion that develops in the wall of the gallbladder. Although the acquired cysts originate from the Rokitansky-Aschoff sinus (RAS), the congenital them, such as the duct of Luschka, are rare. Luschka's duct is a unique and specific tissue component that is histologically different from the inherent bile duct and without the communication to the lumen of the gallbladder. CASEEntities:
Keywords: Case report; Gallbladder; Intramural cysts; Luschka’s duct
Year: 2021 PMID: 33887865 PMCID: PMC8050037 DOI: 10.1016/j.ijscr.2021.105794
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Fig. 1Radiological findings. (A) A cystic lesion (red arrow) was noted in the wall of the gallbladder via enhanced abdominal computed tomography (CT). (B) The cyst was not enhanced by drip infusion cholecystocholangiography-CT (red arrowhead).
Fig. 2Macroscopic and histopathological findings. (A) On the inner surface of the gallbladder, a slightly elevated lesion was observed on the liver bed side at the bottom (red arrow). (B) On the cut surface, several cysts were seen within the wall of the elevated lesion (red arrowhead). (C) Several well-defined bordered cysts were seen in the subserosal layer only. (D) The cyst lining consisted of a monolayer of cuboidal cells. Dense and cellular fibrous tissue encircled the cyst. (E) Small structures suggestive of Luschka’s duct were scattered around the cyst.
Results of immunohistochemical studies.
| Epithelium | |||
|---|---|---|---|
| Antibody (clone, source) | Cyst | Luschka's duct | Mucosa |
| Cytokeratin 7 (SP53, Roche) | +++ | +++ | +++ |
| Cytokeratin 19 (A53B/A2.26, Roche) | +++ | +++ | +++ |
| Cytokeratin 20 (SP33, Roche) | − | − | − |
| CD10 (SP67, Roche) | +* | +* | +* |
| CDX-2 (AMT28, Leica) | − | − | − |
| MUC1 (H23, Roche) | + | + | + |
| MUC2 (MRQ-18, Roche) | + | − | − |
| MUC5AC (AMT28, Novocastra) | − | − | ++ |
| MUC6 (CLH5, Novocastra) | + | + | ++ |
| CEA (TF3H8-1, Roche) | ++ | − | − |
| CA19-9 (121SLE, Roche) | +++ | +++ | +++ |
| Podoplanin (D2-40, Roche) | − | − | − |
| CD34 (QBEnd/10, Roche) | − | − | − |
| −: negative, +: week cytoplasmic positive, ++: strong cytoplasmic positive. | |||
−: negative, +: positive.
Fig. 3Immunohistochemical findings. (A and G) CK7, (B) MUC5AC, (C, D and H) MUC6, (E) MUC2, (F) CEA, (I and J) α-smooth muscle actin (αSMA), and (K, L) desmin. Cytoplasmic expression was observed in the cystic epithelium (A, D, E, F) and Luschka’s duct epithelium (G, H). Cytoplasmic expression was observed in the mucosal epithelium (B, C). Dense cellular fibrous tissue around the cyst and fibromuscular layer showed a positive reaction for αSMA (I and J), but desmin was expressed only in the fibromuscular layer (K) and not in the cyst wall.